{"name":"George Sakoulas, MD","slug":"george-sakoulas-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Octagam","genericName":"Octagam","slug":"octagam","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Octagam","genericName":"Octagam","slug":"octagam","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxOclNPblZWMVlMcmF6Y0JtVlhETlBSQ1NMazFwblFpRGZ3b1dGMWFwaEE3ajJUX2NMODdCNUFjdlhteFI5WHhtNG0zTFhpSWpxUWJwVHdwY1FqWXU0a3U2bFlpYXh4Q0N1UlA1THBUZllpMkNYTzVUa3ZSRWJFRlBNV2J4SHcwSVAwbUZtQjd4VVJNdS1oMkhHakIzSGhpd2w0Wl9JbE9LOHgzZ1ZXUFdLelNodDVrdkNlcUxEeEp2cTAyLUQ5S3ZocmVEWWttQmFISTNzYQ?oc=5","date":"2025-12-21","type":"pipeline","source":"NEJM Clinician","summary":"Innovative Pairing of Beta-Lactamase Inhibitors to Combat Multidrug-Resistant Gram-Negative Pathogens - NEJM Clinician","headline":"Innovative Pairing of Beta-Lactamase Inhibitors to Combat Multidrug-Resistant Gram-Negative Pathogens","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNOWdoQS1EbEU3Uy1YWVdXZ1dyeHV0YmtNNWNhVWxyVDNfN1dENy03NjN0bkFjbjRjUWVCcENRbmtaQTZ2b0Q3NG81YlJmWExSSloyOE1SOWxOSjBQY1Rld1dZLV9LMjNGNlU4V3pJdWNUcjA0d2xUME1TdTVTaUVoN1dGN1d2eHp0?oc=5","date":"2020-08-06","type":"pipeline","source":"BioSpace","summary":"Octapharma Uses IVIG as Potential Treatment for COVID-19 - BioSpace","headline":"Octapharma Uses IVIG as Potential Treatment for COVID-19","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}